148 related articles for article (PubMed ID: 38586882)
1. Exploring the Potential of Natural Products as FoxO1 Inhibitors: an
Gupta A; Haldhar R; Agarwal V; Rajput DS; Chun KS; Han SB; Raj V; Lee S
Biomol Ther (Seoul); 2024 May; 32(3):390-398. PubMed ID: 38586882
[TBL] [Abstract][Full Text] [Related]
2. Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches.
Agarwal V; Haldhar R; Hirad AH; Ahmed B; Han SB; Gupta A; Raj V; Lee S
J Biomol Struct Dyn; 2024 Feb; ():1-13. PubMed ID: 38400742
[TBL] [Abstract][Full Text] [Related]
3. In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease.
V P; A M; N R
Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38204222
[TBL] [Abstract][Full Text] [Related]
4. Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An in-silico approach.
Rajagopal K; Sri VB; Byran G; Gomathi S
Curr Drug Res Rev; 2022; 14(1):61-72. PubMed ID: 34139975
[TBL] [Abstract][Full Text] [Related]
5. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
[TBL] [Abstract][Full Text] [Related]
6. Identification of some novel oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and molecular dynamics studies.
Rajagopal K; Varakumar P; Aparna B; Byran G; Jupudi S
J Biomol Struct Dyn; 2021 Sep; 39(15):5551-5562. PubMed ID: 32720578
[TBL] [Abstract][Full Text] [Related]
7. In-silico screening and molecular dynamics simulation of quinazolinone derivatives as PARP1 and STAT3 dual inhibitors: a novel DML approaches.
Dilipkumar S; Karthik V; Dk S; Gowramma B; Lakshmanan K
J Biomol Struct Dyn; 2023 Sep; ():1-11. PubMed ID: 37735921
[TBL] [Abstract][Full Text] [Related]
8. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
[TBL] [Abstract][Full Text] [Related]
9. An in silico approach for identification of lead compound as FtsZ inhibitor.
Kifayat S; Almuqdadi HTA; Singh RP; Singh M; Abid M; Sanapalli BKR
Mol Divers; 2024 May; ():. PubMed ID: 38775995
[TBL] [Abstract][Full Text] [Related]
10. Lead optimization of
Ojo OA; Adegboyega AE; Taiwo OA; Olowosoke CB; Johnson GI; Umedum NL; Onuh K; Adeduro MN; Nwobodo VO; Elekan AO; Alemika TE; Johnson TO
J Biomol Struct Dyn; 2023 Dec; ():1-15. PubMed ID: 38109128
[TBL] [Abstract][Full Text] [Related]
11. In-silico Design and ADMET Studies of Natural Compounds as Inhibitors of Xanthine Oxidase (XO) Enzyme.
Malik N; Dhiman P; Khatkar A
Curr Drug Metab; 2017; 18(6):577-593. PubMed ID: 28302027
[TBL] [Abstract][Full Text] [Related]
12. Benzothiazole derivatives as p53-MDM2 inhibitors:
N SD; Shivakumar ; Kumar D U; Ghate SD; Dixit SR; Awasthi A; Revanasiddappa BC
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38111168
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking and dynamics guided approach to identify potential anti-inflammatory molecules as NRF2 activator to protect against drug-induced liver injury (DILI): a computational study.
Mili A; Das S; Nandakumar K; Lobo R
J Biomol Struct Dyn; 2023 Nov; 41(19):9193-9210. PubMed ID: 36326112
[TBL] [Abstract][Full Text] [Related]
14. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
15. Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer.
Sun Y; Ai X; Hou J; Ye X; Liu R; Shen S; Li Z; Lu S
Mol Biosyst; 2017 Jan; 13(2):330-337. PubMed ID: 27966721
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening.
Esther Rubavathy SM; Palanisamy K; Priyankha S; Thilagavathi R; Prakash M; Selvam C
J Biomol Struct Dyn; 2023 Nov; 41(19):9492-9502. PubMed ID: 36369945
[TBL] [Abstract][Full Text] [Related]
18. An
Malkaje S; Srinivasa MG; Deshpande N S; Navada S; Revanasiddappa Bc
Curr Drug Res Rev; 2023; 15(1):88-100. PubMed ID: 36017854
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
20. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
